Expanded Access Protocol to Provide Brincidofovir for the Treatment of Serious Adenovirus Infection or Disease
Trial ID or NCT#
NCT02596997
Status
NOT RECRUITING
Purpose
Provide patients with serious AdV infection or disease access to treatment with BCV.
Official Title
An Intermediate-size, Expanded Access Protocol to Provide Brincidofovir for the Treatment of Serious Adenovirus Infection or Disease
Eligibility Criteria
Ages Eligible for Study: Older than 2 Months
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: No
Inclusion Criteria:
- * Confirmed serious AdV infection based on clinical symptoms and laboratory testing showing AdV in the blood or other bodily fluids* Able to swallow medication, either tablet or liquid
Exclusion Criteria:
- * Previous dosing with Brincidofovir* If female, not pregnant or trying to become pregnant
Investigator(s)
Rajni Agarwal
Professor of Pediatrics (Stem Cell Transplantation)
View on ClinicalTrials.gov
